Neuropsychiatric symptoms in Alzheimer’s disease and dementia are a common occurrence, which causes significant distress for individuals affected by the same and their caregivers. Even though the symptoms are severe and have serious implications, NPSs are still under-recognized and owing to lack of advancements, it is often highly challenging to treat. Alzheimer’s and dementia were amongst the earliest of signs or symptoms of neurocognitive issues and the decline of one’s cognitive abilities. Psychiatry pharma franchises in Bengaluru have developed and brought-forward various medicinal products to address these burgeoning challenges of NPSs.
A Statistical Overview
In a research, it was found that more than 5 million people in the United States have Alzheimer’s disease and closely related forms of dementia. This number is estimated to rise in striking fashion and by the year 2050, more than 14 million people will suffer from the same. With treatment of dementia being on the higher end of the price chart, it is extremely difficult for middle-class patients and their family to conduct proper care. Last year itself, over 16 million caregivers were hired to assist elderly citizens with dementia, which means a cumulative total of over 18 billion hours are spent every year in care.
In India, things are not too bright as well. Herein, around 4 million people suffer from some form of dementia. The most common condition amongst them being Alzheimer, which comprises a total of 1.6 million out of the overall number. Alarmingly, by the year 2050, this number is slated to reach close to the 5 million mark.
A big problem in India surrounding dementia is the lack of knowledge amongst citizens concerning the disease. People are negligent about the situation, its causes, and its eventual results. Psychiatry pharma franchises in Bengaluru and other parts of India not only have the task-cut out to provide medicinal care but they also need to spread knowledge about dementia, NPSs, and how individuals can be prepared for the worst.
Neuropsychiatric Symptoms of Alzheimer and Dementia
- Psychotic Symptoms in AD
In this form of symptom, individuals face both occurrences of hallucinations and delusions. Hallucinations are reported to occur less frequently as compared to delusions, especially in isolated situations. Surprisingly, the opposite rings true for other forms of dementia like Lewy bodies and Parkinson’s disease. The hallucinations in AD are majorly different than the ones suffering from psychotic depression and schizophrenia. Herein, the hallucinations are much more visual, less auditory, and in rare cases it is tactile. On the other hand, delusions can be divided into two categories; persecutory delusions, which occur in the early stage of AD and misidentification delusions, which increases with the severity of dementia.
- Sleep Disturbances
Disturbances in sleep is an extremely common symptom in dementia linked with AD. Statistically, it affects a staggering 44% of patients across clinics. Disturbances in sleep cause a wide-number of unsupervised and potentially risky behaviors on part of the suffering individual. This includes pacing down the floor or wandering around and others, all of which can place surrounding members to be at risk of harm.
- Agitation and Anxiety
It is highly common for individuals suffering from AD to be agitated and anxious. The reason behind such conditions can be because of various medical conditions, medical engagements, or any situation that causes the person’s thinking abilities to deteriorate. In this case, individuals become extremely restless, which makes them move around and pace up and down, or makes them sad in certain places or times.
Treatments for neuropsychiatric symptoms in Alzheimer may not have advanced as much as other fields of healthcare, but continuous efforts and proven results are bringing forward a new ray of hope amongst individuals. Psychiatry pharma franchises in Bengaluru and other cities of India boast the capability to identify, nurture, and treat such disorders and diseases.